Gabriel, P.-E.; Horowitz, A.; Guerrero-Ramos, F.; Soria, F.; Moschini, M.; D’Andrea, D.; Pradère, B.; Sfakianos, J.P.; Xylinas, E.
Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives. Cancers 2025, 17, 3555.
https://doi.org/10.3390/cancers17213555
AMA Style
Gabriel P-E, Horowitz A, Guerrero-Ramos F, Soria F, Moschini M, D’Andrea D, Pradère B, Sfakianos JP, Xylinas E.
Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives. Cancers. 2025; 17(21):3555.
https://doi.org/10.3390/cancers17213555
Chicago/Turabian Style
Gabriel, Pierre-Etienne, Amir Horowitz, Felix Guerrero-Ramos, Francesco Soria, Marco Moschini, David D’Andrea, Benjamin Pradère, John P. Sfakianos, and Evanguelos Xylinas.
2025. "Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives" Cancers 17, no. 21: 3555.
https://doi.org/10.3390/cancers17213555
APA Style
Gabriel, P.-E., Horowitz, A., Guerrero-Ramos, F., Soria, F., Moschini, M., D’Andrea, D., Pradère, B., Sfakianos, J. P., & Xylinas, E.
(2025). Therapeutic Intensification Based on Immune Checkpoint Inhibitors in Non-Muscle Invasive Bladder Cancer: State of the Art and Future Perspectives. Cancers, 17(21), 3555.
https://doi.org/10.3390/cancers17213555